Showing results (1071-1080 of 1,142) with videos related to

Sort By:
Pageof 115
Signal Transduction and Targeted Therapy|July 2, 2025
Safety and immunogenicity of an HIV vaccine trial with DNA prime and replicating vaccinia boostYing Liu, Wei Lv, Pu Shan, et al.
Cancer Research|April 24, 2024
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast CancerJie Xia, Lixing Zhang, Xilei Peng, et al.
Acta Pharmacologica Sinica|December 6, 2016
Discovery, synthesis, biological evaluation and structure-based optimization of novel piperidine derivatives as acetylcholine-binding protein ligandsJian Shen, Xi-Cheng Yang, Ming-Cheng Yu, et al.
Journal of Ethnopharmacology|July 21, 2015
Anti-influenza virus effects of crude phenylethanoid glycosides isolated from ligustrum purpurascens via inducing endogenous interferon-γXiao-peng Hu, Min-ming Shao, Xun Song, et al.
Bing Du Xue Bao = Chinese Journal of Virology|March 7, 2008
[Effect of GBV-C/HIV coinfection on HIV/AIDS disease progression and HIV replication]Ting Zhu, Xin-Ping Ding, Yan-Min Wan, et al.
Cell Metabolism|November 12, 2020
Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic TargetsYue Gong, Peng Ji, Yun-Song Yang, et al.
Cell Metabolism|March 12, 2022
The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancerHai Wang, Xingyu Rong, Gan Zhao, et al.
Diabetes Care|October 5, 2023
Plasma Tryptophan-Kynurenine Pathway Metabolites and Risk for Progression to End-Stage Kidney Disease in Patients With Type 2 DiabetesJian-Jun Liu, Jianhong Ching, Hai Ning Wee, et al.
BMC Research Notes|January 31, 2014
Chinese culture permeation in the treatment of Parkinson disease: a cross-sectional study in four regions of ChinaZhen-Xin Zhang, Honglei Chen, Sheng-Di Chen, et al.
Cancer|March 21, 2019
Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trialKe-Da Yu, Si-Yu Wu, Guang-Yu Liu, et al.
Pageof 115